Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Kinetics of abacavir-induced remodelling of the Major Histocompatibility Complex class I peptide repertoire

ABSTRACT: Characterisation of the kinetics of abacavir-induced perturbation of the immunopeptidome of the Major Histocompatibility Complex (MHC) class I molecule HLA-B*57:01.

INSTRUMENT(S): TripleTOF 5600, Q TRAP, Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Patricia Illing

LAB HEAD: Anthony W Purcell

PROVIDER: PXD024331 | Pride | 2021-05-11

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20140923_Pat_con_ABC_B.wiff	Wiff
	20140923_Pat_con_ABC_B.wiff.scan	Wiff
	20140924_Pat_12hr_ABC_B.wiff	Wiff
	20140924_Pat_12hr_ABC_B.wiff.scan	Wiff
	20140924_Pat_16hr_ABC_B.wiff	Wiff

Items per page:

1 - 5 of 134

Similar Datasets

Impacts of HLA-B57 micropolymorphism (MRM)

Project description:Comparison of peptide ligands of major histocompatibility class (MHC) I isolated by immunoaffinity purification from the C1R (Class I reduced) B-lymphoblastoid cell line, transfected with the MHC class I alleles HLA-B*57:01, HLA-B*57:03 and HLA-B*58:01.

2018-10-24 | PXD009850 | Pride

Identification of HLA-B*57:01-restricted endogenous and HIV epitopes

Project description:A novel modified HLA-B*57:01-restricted epitope was identified in one of the reversed-phase fractions following immunoaffinity purification of HLA-peptide complexes from C1R cells expressing HIV envelope protein. Also includes six immunopeptidome datasets from several B57 and env transfected cell lysates.

2018-02-19 | PXD004471 | Pride

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and design of immunotherapeutics

Project description:The features of peptide antigens that contribute to their immunogenicity are poorly understood. Although the stability of peptide-MHC (pMHC) is known to be important, current assays assess this interaction only for peptides in isolation and not in the context of natural antigen processing and presentation. Here, we present a novel method which provides a comprehensive and unbiased measure of pMHC stability for thousands of individual ligands detected simultaneously by mass spectrometry (MS). The method allows rapid assessment of intra- and inter-allelic differences in pMHC stability and reveals broader profiles of stability than previously appreciated. The additional dimensionality of the data facilitated the training of a model which improved the prediction of peptide immunogenicity, specifically of cancer neoepitopes. This assay can be applied to any cells bearing MHC or MHC-like molecules, offering insight into not only the endogenous immunopeptidome, but also that of neoepitopes and pathogen-derived sequences.

2020-11-30 | PXD017839 | Pride

DIA acquisition of the immunopeptidomes of C1R-B*57:01 and C1R-A*02:01 cell lines

Project description:Immunopeptidomes are the peptide repertoires bound by the molecules encoded by the major histocompatibility complex (MHC) (human leukocyte antigen (HLA) in humans). These HLA-peptide complexes are presented on the cell surface for immune T cell recognition. Immunopeptidomics utilizes tandem mass spectrometry (MS/MS) to identify and quantify peptides bound to HLA molecules. Data-independent acquisition (DIA) has emerged as a powerful strategy for deep proteome-wide profiling, but DIA application to immunopeptidomics analyses has so far seen limited use. The dataset deposited here contains the DIA data of the HLA-bound peptides purified and isolated from C1R-B*57:01 and C1R-A*02:01 cell lines.

2023-02-13 | PXD034539 | Pride

MRM (Multiple Reaction Monitoring) quantitation of the blood plasma and serum samples from healthy donors

Project description:Using 30 synthetic bacterial peptides as external standards, we quantified the abundance of identified peptides in the serum and plasma by multiple reaction monitoring (MRM). Of these 30 peptides, 15 were quantified reliably.

2024-06-14 | PXD027793 | Pride

A proteomics approach towards identification and validation of blood-based protein biomarkers for the differentiation of ischemic stroke from intracerebral hemorrhage

Project description:Background & aims: Stroke diagnosis is challenging in the acute phase. We aimed to determine biomarkers for the differentiation of ischemic stroke (IS) from intracerebral hemorrhage (ICH) using SWATH-MS and validate the discovered biomarkers within 24 hours using MRM proteomics. Methods: The study was conducted at Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. Serum samples were collected within 24 hours from acute stroke (IS & ICH) patients & healthy controls. SWATH-MS proteomics identified significantly differentially expressed (SDE) proteins (fold change: 1.5, p<0.05 and confirmed/tentative selection using Boruta random forest) between IS and ICH which were then validated using protein MRM. Cut-off points were determined using Youden Index. Prediction models were developed using forward stepwise multivariate logistic regression analysis. Integrated discrimination improvement index determined the added value of biomarkers to clinical models. Results: Discovery phase included 20 IS, 20 ICH and 40 controls while validation phase included 150 IS and 150 ICH subjects. Total 365 proteins were quantified using SWATH-MS. Between IS and ICH, 20 SDE proteins were identified. Prediction model including clinical variables (sex, hypertension, atrial fibrillation, current smoking, baseline NIHSS) and biomarkers (GFAP, MMP9, APOC1) independently differentiated IS from ICH (accuracy: 92%, sensitivity: 96%, specificity: 69%). Addition of biomarkers improved the discrimination capacity by 26% (p<0.001) compared to clinical variables alone. Conclusion: Our study identified a range of potential protein biomarkers for the differentiation of IS. Protein biomarkers along with clinical predictors might be useful candidates in differentiating IS from ICH in acute settings.

2022-09-21 | PXD032917 | Pride

Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

Project description:The classical HLA-C and the nonclassical HLA-E and HLA-G molecules play important roles both in the innate and adaptive immune system. Starting already during embryogenesis and continuing throughout our lives, these three Ags exert major functions in immune tolerance, defense against infections, and anticancer immune responses. Despite these important roles, identification and characterization of the peptides presented by these molecules has been lacking behind the more abundant HLA-A and HLA-B gene products. In this study, we elucidated the peptide specificities of these HLA molecules using a comprehensive analysis of naturally presented peptides.

2018-04-20 | PXD009531 | Pride

C1R.B*57:01 MHC class I immunopeptidome LC-MSMS

Project description:Characterisation of peptide ligands of Major histocompatibility class (MHC) I isolated by immunoaffinity purification from the C1R (Class I reduced) B-lymphoblastoid cell line, transfected with the MHC class I allele HLA-B*57:01.

2018-10-24 | PXD008570 | Pride

DDA acquisition of the immunopeptidomes of C1R-B*57:01 and C1R-A*02:01 cell lines

Project description:Immunopeptidomes are the peptide repertoires bound by the molecules encoded by the major histocompatibility complex (MHC) (human leukocyte antigen (HLA) in humans). These HLA-peptide complexes are presented on the cell surface for immune T cell recognition. Immunopeptidomics utilizes tandem mass spectrometry (MS/MS) to identify and quantify peptides bound to HLA molecules. The dataset deposited here contains the DDA runs used to generate the spectral libraries of the HLA-bound peptides purified and isolated from C1R-B*57:01 and C1R-A*02:01 cell lines.

2023-02-13 | PXD034429 | Pride

Unsupervised mining of HLA-I peptidomes reveals unsuspected false positives and new binding motifs

Project description:Modern antigen vaccine designs and studies of human leukocyte antigen (HLA)-mediated immune responses rely heavily on the knowledge of HLA allele-specific binding motifs and computational prediction of antigen-HLA binding affinity. Breakthroughs in HLA peptidomics have considerably expanded the databases of natural HLA antigens and enabled detailed characterizations of antigen-HLA binding specificity. However, cautions must be made when analyzing HLA peptidomics data because identified peptides may be contaminants or may weakly bind to the HLA molecules. Here, a hybrid de novo peptide sequencing approach was applied to large-scale mono-allelic HLA peptidomics datasets to uncover new antigens and refine current knowledge of HLA binding motifs. Up to 12-40% contaminations in the form of tryptic peptides were identified in the peptidomics data of HLA alleles whose binding motifs do not involve an arginine or a lysine at the C-terminus. Thousands of these peptides were reported in a community database as positive antigens and might be erroneously used to train prediction models. Furthermore, unsupervised clustering of identified antigens not only revealed additional binding motifs for several HLA class I alleles but also effectively isolated outliers which were confirmed to be false positives in a binding experiment. Overall, our findings expanded the knowledge of HLA binding specificity and indicated that a more careful HLA peptidomics data interpretation protocol is needed to ensure the high quality of community antigen databases.

2021-09-17 | PXD028088 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data